Loading…
Based on limited metadata, the FDA issued a Warning Letter to Goldstar Distribution, a dietary supplement distributor, on April 10, 2019. While the specific subject line is unavailable, the letter indicates regulatory concerns within the dietary supplement product category. Without access to the full letter text, the precise nature of the violations cannot be determined from the metadata provided.